Guinea pigs genetically deficient in the second (C2) or fourth component of complement (C4) generally appear healthy in contrast to humans with a C2 or C4 deficiency. However, upon investigation of these genetic deficiencies in guinea pigs for signs of dysregulation in the humoral immune system and especially autoantibodies, many complement-deficient guinea pigs (>50%) had elevated levels of serum IgM and higher concentrations of anti-hapten (dinitrophenyl) antibodies as signs of polyclonally stimulated antibody synthesis. In addition, a significant number of the complement-deficient animals, on average 30%, had IgM rheumatoid factors in their sera compared with <1% of the normal animals. These observations, therefore, indicate that guinea pigs, genetically deficient in C2 or C4, show characteristics of immune complex disease in general.
Introduction
Numerous reports have established that humans, genetically de- ficient in components of the classical pathway of complement (C),' are suspectible to immune complex diseases in general and the juvenile type of systemic lupus erythematosus (SLE) in particular (for reviews, [1] [2] [3] . Generally, patients with SLE have multiple autoantibodies, e.g., against DNA or serum proteins (4) .
In contrast, guinea pigs genetically deficient in the second (C2D-GP) or fourth component of C (C4D-GP) appear healthy (5, 6) , even though an impaired humoral immune response was previously shown for both C4D-GP (5, 7) and C2D-GP (5) . Although these animals have no overt clinical symptoms, we tested the sera ofthese genetically C-deficient guinea pigs for serologic abnormalities in order to determine whether they are predisposed to autoimmunity. In particular, we tested for circulating immune complexes, antibodies against complement proteins, and socalled rheumatoid factors, which is a collective term for immunoglobulins of the IgM or IgG class specific for antigenetic determinants on homologous or heterologous aggregated IgG (6, (8) (9) (10) (11) (12) . We also determined levels of serum IgM, IgG, and Receivedfor publication 4 December 1985 and in revisedform 26 March 1986.
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antibodies against the hapten dinitrophenyl (DNP), in that a common feature of human SLE and murine SLE models is hypergammaglobulinemia and spontaneously elevated levels of various anti-hapten antibodies ( 13, 14) .
Our results suggest, that these C-deficient guinea pigs may serve as an experimental model to study the contribution and pathogenetic role of C deficiency during the development and sustaining of auto-immune diseases, especially for the role of these deficiencies in SLE in humans.
Methods
Experimental animals. C4D-GP (National Institutes of Health origin 1974) and C2D-GP (15) came from our in-house breeding colony. Both strains are partially inbred up to the tenth generation. The C-deficiency state was confirmed by negative results in C2 or C4 hemolytic assays (15, 16). Guinea pigs of inbred strains 2 and 13 served as controls. The strain 13 is major histocompatibility complex (MHC) identical to the C4-deficient strain (17). Healthy animals of both sexes, at least 6-9 mo old were used for the studies and the different strains were comparable in terms of age and sex. All animals were held in closed colonies and received the same standardized diet. In addition, C-deficient guinea pigs ofboth sexes between 2 wk and 5 mo ofage were examined for a possible age-dependent development of the investigated parameter.
Blood was obtained by cardiac puncture, allowed to clot for 2 h at room temperature, and then centrifuged. Serum was stored in small aliquots at -70'C. All cardiac punctures were done under anesthesia Solid-phase enzyme-linked immunosorbent assay (ELISA) for circulating immune complexes. A solid-phase C3 immunoassay was used as described previously (18) with minor modifications to detect circulating immune complexes bearing C3b. A mouse monoclonal antibody of fy I subclass with a weak affinity for native guinea pig C3 but a strong affinity for its fragments C3b and C3c was used (19) . U-shaped wells of flexible polyvinyl chloride microtiter plates (Dynatech Germany, Niirtingen, Federal Republic ofGermany) were coated with 20 Al ofanti-C3 (purified by ammonium sulfate precipitation) in 0.1 M NaHCO3, pH 9.6 (15 ,g/ ml, protein concentration was determined according [20] to Bradford) overnight at 4°C. Plates were then washed with phosphate-buffered saline (PBS) and 200 gl of PBS-bovine serum albumin (BSA) was added to each well for 1 h at 4°C to cover unreacted sites. Then 50 Ml of either standard (see below) or serum diluted 1/21 in PBS-BSA-EDTA 0.1 M, pH 7.2, was added for 1 h at room temperature. After washing with PBS containing 0.05% Tween, 20 Ml of peroxidase-labeled rabbit anti-guinea pig Ig (Dakopatts, Hamburg, Federal Republic of Germany) 1:500 in PBS-BSA was added and developed using 2,2'-azino-di(-3-ethylbenzthiazoline sulfonate [5] ) (Boehringer, Mannheim, Federal Republic ofGermany) as substrate. Optical densities (OD) were read in an automatic ELISA reader at 414 nm (Flow Laboratories, Meckenheim, Federal Republic of Germany).
The standards were prepared by adding heat-aggregated (20 mm, 63°C) guinea pig gamma-globulin (AGG) to fresh guinea pig serum and incubating for 30 min at 37°C. The binding of AGG to the anti-C3-by AGG-which was detected by the antibody, and monomeric IgG did not interfere with the assay. A sensitivity of 2-4 ,ug AGG/ml was consistently obtained.
Detection ofrheumatoidfactors. Guinea pig antibodies directed against heterologous mouse gamma-globulins were detected by solid-phase ELISA. Different subclasses of mouse monoclonal antibodies were used as antigens to detect subclass-specific rheumatoid factors. These monoclonal antibodies were directed against antigens not present in animal sera, i.e., bacterial antigens. In particular, we used: monoclonal y 1, specificity for antiplasmid-encoded outer membrane protein ofEscherichia coli (anti-TraTp) (21); monoclonal 'y3, specificity anti-K12 lipopolysaccharide (unpublished); and monoclonal 8y2a, specificity anti-TraTp (21).
They I monoclonal antibody was purified by 40% ammonium sulfate precipitation, the -y2a and y3 monoclonals by Protein A-Sepharose (Deutsche Pharmacia, Freiburg, Federal Republic of Germany) as described (22). Each antibody was bound to U-shaped wells of flexible microtiter plates (Dynatech Germany) in duplicate overnight at 4VC using 20 Ml of a 15 Ag/ml solution of protein in 0.1 M NaHCO3, pH 9.6. The remaining steps were carried out as described above.
A similar solid-phase immunoassay was performed to assess the serum levels of guinea pig IgM-rheumatoid factor (RF) for homologous IgG. Guinea pig -y2 was prepared according to Furuichi et al. (23) and further purified by preparative isoelectric focusing in granulated gels . A solution of 30 Mg/ml covered the microtiter plates. IgM-RF were detected by polyclonal sheep anti-guinea pig IgM (Nordic, Tilburg, The Netherlands) diluted 1:1,000 in PBS-BSA, and developed with peroxidase-labeled rabbit anti-sheep Ig (Dakopatts), 1:500 in PBS-BSA.
Solid-phase ELISA for antibodies to C3b or C3. Guinea pig C3 was prepared according to Burger et al. (19) and further purified by fast protein liquid chromatography over a column containing the anionic exchanger Mono Q (Deutsche Pharmacia). The elution buffer was 0.01 M Tris-HCI, pH 8.5, and an NaCI gradient ranged from 0.03 to 0.42 M NaCi. The preparation, which eluted at 0.21 M NaCi, had a protein content of 24 mg/ml; it gave a single homogeneous line with the appropriate molecular weight (180,000 mol wt) when applied to an analytical SDS-PAGE, and it was hemolytically active.
Guinea pig C3b was prepared according to Burger et al. (19) and further purified by fast protein liquid chromatography with the same procedure as described above for C3. The preparation, which eluted at 0.22 M NaCi, had a protein content of 3 mg/ml; it gave a single homogenous line on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (170,000 mol wt), and it was hemolytically inactive. 20 Al of C3b (40 Ag/ml) or C3 (100 Mg/ml) in PBS was bound to Ushaped wells of flexible microtiter plates (Dynatech) overnight at 40C. The following steps were the same as described above, except serum was diluted in PBS-EDTA 0.01 M, pH 7.4 the C-deficient guinea pigs. The statistical analysis of the data gave no hint for elevations of this class of gamma-globulins for the C-deficient guinea pigs in comparison with the control animals (data not shown).
IgM antibodies to DNP. Serum samples were analyzed for IgM antibodies to DNP (Fig. 2) . The mean value (expressed as GD) of the control animals was 92±40. Three control guinea pigs (3.3%) had levels exceeding 2 SD, whereas 34.3% of the C2D-GP and 80.3% of the C4D-GP had elevated levels of IgM antibodies to DNP. These differences were highly significant (P < 0.001).
Antibodies against heterologous mouse gamma-globulins and rheumatoidfactors in guinea pig sera. The normal concentration ofguinea pig antibodies to heterologous mouse gamma-globulins of the y2a, y3, or y 1 subclass was assessed by testing serum samples from 124 normal guinea pigs of two different strains. Three control animals (2.4%) had levels above 2 SD in the anti-mouse y2a assay (Fig. 3 A) . In contrast, 12 of 138 C2D-GP (8.7%) had values exceeding 2 SD. Using Fisher's exact 2 X 2 table test, the difference compared with the control animals proved to be significant (P = 0.05). Likewise levels above 2 SD were found in the C4D group: 12 of 130 animals (9.2%); compared with the control animals, the difference was significant (P = 0.04). Using mouse y3 globulin as antigen (Fig. 3 B) , the sera of four control animals (3.2%) exceeded 2 SD. Again a higher number of the C-deficient GP were positive (= >2 SD) in this assay, i.e., 17 of the C2D-GP group (12.2%) and 16 animals of the C4D-GP group (12.3%). P values in every case were <0.005.
As in the anti-'y2a assay, those values above 2 SD were consistently higher in the C-deficient animals than in the control animals. After testing the guinea pig sera for antibodies against mouse 'y 1-globulin (Fig. 3 C) , similar results were found. Two control sera (1.6%) had levels above 2 SD, whereas this applied to 16 To determine whether the C-deficient guinea pigs have IgM-RF recognizing homologous gamma-globulin, we tested reactivity against homologous guinea pig immunoglobulin, using purified guinea pig y2-globulins as antigen (Fig. 4) . One control guinea pig (0.84%) had levels exceeding 2 SD. In contrast 15 of 67 C2D-GP (22.4%) and 27 of 71 C4D-GP (38.0%) were positive in this assay. Using Fisher's exact 2 X 2 table test, these differences were highly significant (P < 0.001). Most C2D-GP and all C4D-GP reactive against heterologous mouse y2a had also IgM-RF recognizing homologous y2 (P. Pearson chi-square <0.001).
Circulating immune complexes in guinea pig sera. The results of the C3 assay (see Methods) for detecting immune complexes bearing C3b were hampered by the fact that guinea pig antibodies against mouse y1 globulins did interfere with this assay (the anti-C3 is of yl subclass). In fact, three of the four control animals (3.2%), which had levels above 2 SD, were also reactive against a panel of four different yl monoclonals, indicating that their positive reaction in the immune complex assay was probably due to anti-y 1 antibodies. Comparably most ofthe 19 C2D-GP (13.8%) and 19 C4D-GP (14.6%) positive in the immune complex assay also reacted with these different y 1 monoclonals except two animals of each group, which reacted exclusively with the anti-C3 antibody for detection of immune complexes (data not given).
Antibodies against C3b. The mean value in the ELISA for antibodies to C3b was 87±61 (+ 1 SD), expressed in OD, for the control animals (data not shown). However, the difference between the C-deficient and normal guinea pigs was not significant: six control guinea pigs (4.8%), seven C2D-GP (5.1%), and eight C4D-GP (6.15%) had levels above 2 SD. None ofthese sera were reactive with native C3 in the ELISA (data not shown). Therefore reactivity against C3b may have been due to an antigenetic neodeterminant not shared by native C3.
One C2D-GP had exceedingly high antibody titers to C3b. We investigated this further with an inhibition ELISA: C3b was bound to the wells of a microtiter plate as described above. We then tried to block binding of the guinea pig autoantibody to C3b by preincubation of bound C3b with different mouse monoclonal antibodies to guinea pig C3b (all of y 1 subclass). As shown in Fig. 5 constant, albeit weak, inhibition was seen with two ofthree anti-C3b monoclonal antibodies; this inhibition was slightly enhanced when adding both monoclonals together. Interassay correlation in C-deficient guinea pig sera. No correlation was found between the results of the different guinea pig-anti-mouse y i, y2, or -y3 assays, because most animals were only positive in one of these assays (data not given).
When comparing serum IgM levels with levels of guinea pig-anti-mouse immunoglobulins or IgM-RF, the correlation was significant, albeit weak; e.g., r = 0.298 and P = 0.001 for IgM-RF. In addition, serum IgM levels correlated well with levels of IgM antibodies to DNP, as shown in Fig. 6 .
Influence of sex and age. Matching the C-deficient guinea pigs for sex revealed no difference in any ofthe assays described above. When young C-deficient animals (between 2 wk and 5 mo of age) were examined, they clearly had elevated IgM and IgM anti-DNP antibody levels ( Fig. 7; for comparison see Fig.   1 and 2). Both parameters exclusively reflect antibodies of childish origin and transferred maternal antibodies are therefore excluded.
With respect to the presence of IgM-RF, it was interesting to observe that a tendency of the adult guinea pig, namely the more common presence ofIgM-RF in the C4D-GP vs. the C2D-GP (38% vs. 22.4%; see Fig. 4 ) was even more pronounced in young animals: only 1 of 38 C2D-GP (2.6%) had elevated levels of IgM-RF compared to 6 of 1 1 C4D-GP (55%). The seemingly more common presence of IgM-RF in young C4D-GP in comparison to their adult counterparts is due to the small number of young animals available and statistically not significant.
Discussion
The etiology and many of the details of pathogenesis of SLE and related syndromes have not been elucidated, but it is well established that autoimmune diseases frequently are associated with multiple autoantibodies (for review, 4) . It is known, however, that humans, genetically deficient in components of the classical C pathway, are prone to immune complex diseases, particularly juvenile SLE (1-3). The experiments described here show that guinea pigs, genetically deficient in either C2 or C4, have unusual antibodies such as rheumatoid factors in their sera, although they appear healthy. By necessity this phenomenon was limited to only a subpopulation of all C-deficient animals tested, e.g., 22.4% of the C2D-GP and 38.4% of the C4D-GP had levels of IgM-RF exceeding normal mean + 2 SD, compared with 0.8% for control animals.
Taking together the results ofthe RF assays for heterologous mouse gamma-globulin of y 1, 'y3, or y2a subclass, 25.7% ofthe C-deficient guinea pigs vs. 6.5% of the control animals had antibodies against heterologous mouse gamma-globulin. The RF assays specific for certain subclasses did not correlate well with one another, i.e., most C-deficient guinea pigs were positive in only one of these assays. We therefore assume that by further extending the number of antigens tested, the absolute number of C-deficient guinea pigs showing autoantibodies will increase. Some C-deficient guinea pigs had high titers of antibodies against C3b but not native C3, which is of particular interest, in that it is known that some SLE patients have autoantibodies against the classical pathway C3 convertase (25) . However, the difference in incidence to normal animals did not prove to be significant. (27) and increased in vitro spontaneous immunoglobulin synthesis (28). Secondly, a general feature of all murine SLE models (14) is hypergammaglobulinemia and increased antihapten antibody levels (13) . Interestingly, experimentally induced polyclonal B cell stimulation in mice in vivo also led to elevated levels of IgM-RF, anti-DNP antibodies, anti-DNA antibodies (29-31), and other autoantibodies (32), as well as to hypergammaglobulinemia, whereby elevation ofIgM was a general phenomenon, but elevation of IgG dependent on the stimulus used for polyclonal activation (33) . However, we could only show a weak correlation between levels of serum IgM and IgM-RF in C-deficient guinea pigs. This is in accordance with observations made in murine SLE strains, where hypergammaglobulinemia and increased anti-hapten antibody levels are a general phenomenon, but expression of the different autoantibodies is markedly strain-dependent and only weakly correlates with serum IgM levels (34) .
Several points, however, indicate that these C-deficient guinea pigs are a distinct entity: in contrast to murine SLE models there is no sex dependency and even young GP show these phenom- In addition deficiencies in Cl or its subunits-their genes are probably not MHC-linked-are also associated with IC-disease.
Regarding the question of linkage it is noteworthy that C2-and C4-deficient guinea pigs differ in their MHC alleles (15, 17). It is important to note that the strain 13, which has the same MHC alleles as the C4D strain but normal C4 levels, was completely normal in all assays tested. These observations strengthen the hypothesis that C deficiency itself is responsible for the association of C deficiency and autoimmune disease in humans.
Recently, C2D-GP and C4D-GP were shown to have an impaired humoral immune response to a T cell-dependent antigen (5). We therefore proposed that C3 contributes to reaching a normal humoral immune response in guinea pigs. Our findings here support the concept that the C system might have a regulatory role in cells associated with the production of immunoglobulins. With regard to T cell functions, earlier observations have failed to show an influence ofC4 deficiency in guinea pigs: C4D-GP respond well to specific antigen or mitogen-induced proliferation in vitro (52) and induction of immunologic tolerance appeared normal (53) .
Independent of the mechanism, our results suggest that C2-and C4-deficient guinea pigs may serve as an experimental model to study the mechanism of the association of C deficiency and autoimmune disease in humans.
